Revenue (Quarterly) Chart

View Revenue (Quarterly) for ODYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
March 31, 2026 0.082M
December 31, 2025 0.439M
September 30, 2025 0.149M
June 30, 2025 0.362M
March 31, 2025 2.065M
December 31, 2024 1.304M
September 30, 2024 1.292M
June 30, 2024 1.181M
March 31, 2024 0.187M
December 31, 2023 1.946M
September 30, 2023 0.11M
June 30, 2023 0.674M
March 31, 2023 0.303M
December 31, 2022 0.159M
September 30, 2022 0.134M
June 30, 2022 0.37M
March 31, 2022 0.002M
December 31, 2021 0.066M
September 30, 2021 0.023M
June 30, 2021 0.274M
March 31, 2021 0.024M
December 31, 2020 0.405M
September 30, 2020 0.012M
June 30, 2020 0.034M
March 31, 2020 0.04M
Date Value
December 31, 2019 0.309M
September 30, 2019 0.128M
June 30, 2019 0.12M
March 31, 2019 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 0.00
June 30, 2013 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Omnicell, Inc. 309.88M
Alpha Tau Medical Ltd. 0.00
Carlsmed, Inc. 16.12M
Vaso Corp. 19.36M
Global Innovative Platforms, Inc. 0.1065M